Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private

BSE6236.4513.1 (+0.21 %)

PREV CLOSE ( ) 6223.35

OPEN PRICE ( ) 6350.00

BID PRICE (QTY) 6241.50 (6)

OFFER PRICE (QTY) 6255.85 (2)

VOLUME 503

TODAY'S LOW / HIGH ( )6198.00 6350.00

52 WK LOW / HIGH ( )2603.2 7794

NSE6239.709.25 (+0.15 %)

PREV CLOSE( ) 6230.45

OPEN PRICE ( ) 6389.95

BID PRICE (QTY) 6237.10 (1)

OFFER PRICE (QTY) 6240.00 (2)

VOLUME 13382

TODAY'S LOW / HIGH( ) 6190.00 6389.95

52 WK LOW / HIGH ( )2603.6 7790

Chairman	Davuluri Rama Mohan Rao
Managing Director	Davuluri Saharsh Rao
Company Secretary	Sarada Bhamidipati
Vice Chairman	Davuluri Sucheth Rao
Non Executive Independent Director	Bharati Rao Nirmala Murthy Homi Rustam Khusrokhan Prasad Raghava Menon
Non Independent & Non Executive Director	Christopher M Cimarusti

Incorporation Year : 07-01 1984

Registered Office :

Address : 11th Floor (5th Office Level),Phoenix I V Y Building, Plot No.573 A- I I I,Road No. 82, Jubilee Hills Hyderabad,
Telangana-500033 .

Phone : 040-67611600 / 67611700

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE,MCX